成分分析

UPLC-Q TOF MS/MS法测定谷赖胰岛素注射液一级结构*

  • 毛紫娟 ,
  • 徐艳梅 ,
  • 乔晓宁 ,
  • 高燕霞
展开
  • 1.河北科技大学 化学与制药工程学院, 石家庄 050091;
    2.河北省药品医疗器械检验研究院国家药品监督管理局仿制药质量控制与评价重点实验室, 石家庄 050227
第一作者 Tel:15531727212;E-mail:m15531727212@163.com
**Tel:(0311)69086005;E-mail:657968434@qq.com

收稿日期: 2024-09-06

  网络出版日期: 2025-11-13

基金资助

*中央引导地方科技发展资金项目(216Z4802G)

Determination of the primary structure of insulin glulisine injection by UPLC-Q TOF MS/MS*

  • MAO Zi-juan ,
  • XU Yan-mei ,
  • QIAO Xiao-ning ,
  • GAO Yan-xia
Expand
  • 1. Hebei University of Science and Technology, School of Chemical and Pharmaceutical Engineering, Shijiazhuang 050091, China;
    2. Hebei Institute for Drug and Medical device Control, NMPA Key Laboraory for Quality Control and Evaluation of Generic Drug, Shijiazhuang 050227, China

Received date: 2024-09-06

  Online published: 2025-11-13

摘要

目的: 使用超高效液相色谱-四极杆飞行时间串联质谱法(UPLC-Q TOF MS/MS)对速效胰岛素制剂谷赖胰岛素注射液一级结构进行测定。方法: 使用二硫苏糖醇(DTT)和碘乙酰胺(IAM)对谷赖胰岛素注射液进行还原烷基化前处理,通过UPLC-Q TOF MS/MS分析其一级结构。氨基酸序列测定采用Waters ACQUITY UPLC CSH C18色谱柱(3 mm×150 mm,1.7 μm),流动相为0.1%甲酸水溶液,流动相B为0.1%甲酸乙腈溶液,梯度洗脱,流速0.3 mL · min-1;采用电喷雾离子源正离子模式和MSE采集模式进行数据采集,通过优化质谱参数,对谷赖胰岛素注射液进行一级结构测定,同时考察该方法对精蛋白重组人胰岛素注射液的适用性。结果: 谷赖胰岛素A链与B链一级质量数准确,氨基酸序列覆盖率良好,通过b/y离子分析,A链和B链前5个强度高的b/y离子的离子强度RSD均在10.0%以内,专属性强,重复性好,对精蛋白重组人胰岛素注射液也具有良好的适用性。结论: 该方法操作简便快速、灵敏、准确,可用于谷赖胰岛素注射液及其他胰岛素类似物制剂的一级结构测定。

本文引用格式

毛紫娟 , 徐艳梅 , 乔晓宁 , 高燕霞 . UPLC-Q TOF MS/MS法测定谷赖胰岛素注射液一级结构*[J]. 药物分析杂志, 2025 , 45(6) : 921 -931 . DOI: 10.16155/j.0254-1793.2024-1116

Abstract

Objective: To determine the primary structure of insulin glulisine injection using ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (UPLC-Q TOF MS/MS). was used to determine the primary structure of insulin glulisine injection. Methods: The primary structure of insulin glulisine injection was analyzed by UPLC-Q TOF MS/MS following reductive alkylation pretreatment using dithiothreitol and iodoacetamide. The amino acid sequence was determined on a Waters ACQUITY UPLC CSH C18 column (3 mm×150 mm, 1.7 μm). Mobile phase A was 0.1% formic acid aqueous solution, and mobile phase B was 0.1% formic acid acetonitrile solution. Employing gradient elution at a flow rate of 0.3 mL · min-1. Data acquisition utilized positive electrospray ionization mode and MSE acquisition mode. The mass spectrometry parameters were optimized to determine the primary structure of insulin glulisine injection, with concurrent assessment of the method's applicability to isophane protamine recombinant human insulin injection. Results: The primary mass numbers of insulin glulisine chain A and chain B were accurate, and the amino acid sequence coverage was satisfactory. For b/y ions, the RSD of intensity for the five highest-intensity b/y ions per chain (A and B) was below 10.0%. The method demonstrated specificity and repeatability, with confirmed applicability to isophane protamine recombinant human insulin injection. Conclusion: The method is simple, rapid, sensitive and accurate, and can be used for the primary structure determination of insulin glulisine injection and other insulin analogues drug products.

参考文献

[1] 侯清涛,李芸,李舍予,等.全球糖尿病疾病负担现状[J].中国糖尿病杂志,2016,24(1):92
HOU QT,LI Y,LI SY,et al.The global burden of diabetes mellitus[J].Chin J Diabetes,2016,24(1):92
[2] 王学光. 二甲双胍联合阿卡波糖治疗2型糖尿病临床疗效分析[J].糖尿病新世界,2022,25(11):102
WANG XG.Clinical analysis of metformin combined with acarbose in the treatment of type 2 diabetes[J].Diabetes New World,2022,25(11):102
[3] LAVERY LA,SULUDERE MA,RYAN E,et al.The infected diabetic foot:analysis of diabetic and non-diabetic foot infections[J].Wound Repair Regen,2024,32(4):360
[4] 范梦迪,李俊,付威,等.SGLT-2抑制剂治疗2型糖尿病合并非酒精性脂肪肝[J].西部医学,2021,33(10):1496
FAN MD,LI J,FU W,et al.Curative effect of SGLT-2 inhibitors on type 2 diabetes mellitus combined with nonalcoholic fatty liver disease[J].Med J West China,2021,33(10):1496
[5] WANG Q,CHENG HM,JIANG SS,et al.The relationship between diabetic retinopathy and diabetic nephropathy in type 2 diabetes[J].Front Endocrinol,2024,15:1292412
[6] PEDERSEN FN,STOKHOLM L,ANDERSEN N,et al.Risk of diabetic retinopathy according to subtype of type 2 diabetes[J].Diabetes,2024,73(6):977
[7] 尹华静,余珊珊,尹茂山,等.重组人胰岛素类似物研发进展和安全性特点[J].中国新药杂志,2018,27(21):2578
YIN HJ,YU SS,YIN MS,et al.Research progress and safety characteristics of recombinant human insulin analogues[J].Chin J New Drugs,2018,27(21):2578
[8] 朱大龙,张红.谷赖胰岛素:一种新型速效人胰岛素类似物[J].药品评价,2012,9(22):47
ZHU DL,ZHANG H.Insulin glulisine:a new rapid-acting insulin analogue[J].Drug Eval,2012,9(22):47
[9] 钱建钦,何佳佳,朱坤丹,等.多种质谱解离技术对缩宫素结构表征的比较研究[J].中国现代应用药学,2023,40(6):803
QIAN JQ,HE JJ,ZHU KD,et al.Characterization of oxytocin by different kinds of dissociation methods using high resolution mass spectrometry:a comparative study[J].Chin J Mod Appl Pharm,2023,40(6):803
[10] 杜加亮,于传飞,王文波,等.重组抗IL-36受体单克隆抗体药物的质量控制研究[J].山西医科大学学报,2022,53(10):1331
DU JL,YU CF,WANG WB,et al.Study on quality control of recombinant anti-IL-36 receptor monoclonal antibody[J].J Shanxi Med Univ,2022,53(10):1331
[11] 周勇,王丽,于传飞,等.PEG化重组人促红素质量控制方法和标准研究[J].药物分析杂志,2012,32(4):661
ZHOU Y,WANG L,YU CF,et al.Study on methods and requirements for quality control of Pegylated Erythropoietin(PEG-EPO)[J].Chin J Pharm Anal,2012,32(4):661
[12] 付志浩,武刚,李萌,等.重组抗白细胞介素23单克隆抗体的质量研究[J].中国新药杂志,2021,30(19):1738
FU ZH,WU G,LI M,et al.Quality study of recombinant anti-interleukin-23 monoclonal antibodies[J].Chin J New Drugs,2021,30(19):1738
[13] 吴宏斌,邱文娜,李磊,等.重组艾塞那肽RP-HPLC法肽图分析[J].中国医药科学,2016,6(7):59
WU HB,QIU WN,LI L,et al.Peptide mapping analysis of recombinant Exendin-4 by RP-HPLC[J].Chin Med Pharm,2016,6(7):59
[14] 周艳卿,蒋小岗.Edman降解中异硫氰酸苯酯新修饰位点的发现和验证[J].色谱,2016,34(8):752
ZHOU YQ,JIANG XG.Discovery and validation of a novel modification by phenyl isothiocyanate in Edman degradation[J].Chin J Chromatogr,2016,34(8):752
[15] 田沛霖,张国林.重组人胰岛素原料药N末端氨基酸序列的测定[J].中国合理用药探索,2020,17(12):89
TIAN PL,ZHANG GL.Determination of the N-terminal amino acid sequence in the API of recombinant human insulin[J].Chin J Rational Drug Use,2020,17(12):89
[16] 郭玮,于传飞,李萌,等.N端测序作为单克隆抗体常规放行分析方法的探讨[J].生物工程学报,2014,30(9):1473
GUO W,YU CF,LI M,et al.N terminal sequencing for practical detection of monoclonal antibody[J].Chin J Biotechnol,2014,30(9):1473
[17] RÉVÉSZ Á,ROKOB TA,JEANNE DFD,et al.Optimal collision energies and bioinformatics tools for efficient bottom-up sequence validation of monoclonal antibodies[J].Anal Chem,2019,91(20):13128
[18] KURIL AK,SARAVANAN K.High-throughput method for peptide mapping and amino acid sequencing for calcitonin salmon in calcitonin salmon injection using ultra high performance liquid chromatography-high resolution mass spectrometry(UHPLC-HRMS)with the application of Bioinformatic tools[J].J Pharm Biomed Anal,2024,243:116093
[19] BABOVIĆ M,SHLIAHA PV,GIBB S,et al.Effective amino acid sequencing of intact filgrastim by multimodal mass spectrometry with topdownr[J].J Am Soc Mass Spectrom,2022,33(11):2087
[20] LEVY MJ,GUCINSKI AC,BOYNE MT.Primary Sequence confirmation of a protein therapeutic using top down MS/MS and MS(3)[J].Anal Chem,2015,87(14):6995
[21] 胡馨月,丁晓丽,孙悦,等.利用LC-MS/MS法解析化学修饰型胰岛素类似物的氨基酸序列[J].中国新药杂志,2023,32(3):301
HU XY,DING XL,SUN Y,et al.Identification of amino acid sequence of chemically modified insulin analogues by LC-MS/MS[J].Chin J New Drugs,2023,32(3):301
文章导航

/